| RS1562651617 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 4 |
| RS1562653663 |
PEX3
|
Health Risk |
Pathogenic |
— |
| RS1562654527 |
PEX3
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 1A (Zellweger), Peroxisome biogenesis disorder 1A (Zellweger) |
| RS1562654984 |
PEX3
|
Health Risk |
Pathogenic |
— |
| RS1562656759 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS1562656975 |
GLI3
|
Health Risk |
Likely pathogenic |
GLI3-related disorder, GLI3-related disorder |
| RS1562657370 |
GLI3
|
Health Risk |
Likely pathogenic |
— |
| RS1562657560 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS1562658303 |
GLI3
|
Health Risk |
Likely pathogenic |
— |
| RS1562659544 |
SKIC2
|
Health Risk |
Pathogenic |
Trichohepatoenteric syndrome 2, Trichohepatoenteric syndrome 2 |
| RS1562660214 |
DNAH11
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1562664845 |
PMS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome |
| RS1562664890 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS1562664935 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1562667078 |
GLI3
|
Health Risk |
Conflicting classifications of pathogenicity |
8 conditions, Greig cephalopolysyndactyly syndrome |
| RS1562668233 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1562669585 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1562671039 |
PMS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1562677687 |
PMS2
|
Health Risk |
Likely pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS1562677770 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS1562678257 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1562678869 |
GUSB
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 7, Mucopolysaccharidosis type 7 |
| RS1562684798 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1562685713 |
FIG4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4J, Charcot-Marie-Tooth disease type 4 |
| RS1562686929 |
BBS9
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1562687295 |
GSDME
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 5, Autosomal dominant nonsyndromic hearing loss 5 |
| RS1562687726 |
GSDME
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 5, Autosomal dominant nonsyndromic hearing loss 5 |
| RS1562688519 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1562689635 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 4 |
| RS1562690271 |
GLI3
|
Health Risk |
Pathogenic |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS1562690527 |
PMS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Lynch syndrome 4, Lynch syndrome 4 |
| RS1562691736 |
DNAH11
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Situs inversus |
| RS1562695294 |
PMS2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 4 |
| RS1562700083 |
HOXA1
|
Health Risk |
Pathogenic |
Bosley-Salih-Alorainy syndrome, Bosley-Salih-Alorainy syndrome |
| RS1562711587 |
PMS2
|
Health Risk |
Likely pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS1562711915 |
GCK
|
Health Risk |
Pathogenic |
Monogenic diabetes, Maturity-onset diabetes of the young |
| RS1562713041 |
GCK
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS1562715296 |
GCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1562715426 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young type 2 |
| RS1562715574 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS1562715620 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1562715657 |
GCK
|
Health Risk |
Pathogenic |
Monogenic diabetes, Maturity-onset diabetes of the young |
| RS1562717053 |
GCK
|
Health Risk |
Pathogenic |
Permanent neonatal diabetes mellitus 1, Maturity-onset diabetes of the young type 2 |
| RS1562717232 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1562718043 |
GCK
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS1562718649 |
ACTB
|
Health Risk |
Conflicting classifications of pathogenicity |
Baraitser-Winter syndrome, Baraitser-Winter syndrome 1 |
| RS1562718846 |
ACTB
|
Health Risk |
Likely pathogenic |
— |
| RS1562719029 |
GCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1562719316 |
ACTB
|
Health Risk |
Likely pathogenic |
— |
| RS1562719705 |
GCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS1562719786 |
GCK
|
Health Risk |
Uncertain significance/Uncertain risk allele |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS1562719872 |
ACTB
|
Health Risk |
Conflicting classifications of pathogenicity |
Baraitser-Winter syndrome 1, Baraitser-Winter syndrome 1 |
| RS1562720119 |
ACTB
|
Health Risk |
Likely pathogenic |
Baraitser-Winter syndrome 1, Intellectual disability |
| RS1562722163 |
CDK13
|
Health Risk |
Likely pathogenic |
Congenital heart defects, dysmorphic facial features |
| RS1562737230 |
ASL
|
Health Risk |
Pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1562742141 |
ASL
|
Health Risk |
Pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1562747728 |
AUTS2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1562753388 |
AHI1
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS1562767666 |
CDK13
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1562774655 |
SLC25A13
|
Health Risk |
Pathogenic |
Neonatal intrahepatic cholestasis due to citrin deficiency, Neonatal intrahepatic cholestasis due to citrin deficiency |
| RS1562774778 |
SLC25A13
|
Health Risk |
Pathogenic |
— |
| RS1562775040 |
SYNE1
|
Health Risk |
Likely pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS1562782355 |
DNAH8
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1562782419 |
SLC25A13
|
Health Risk |
Conflicting classifications of pathogenicity |
Citrin deficiency, Citrin deficiency |
| RS1562787582 |
ESR1
|
Health Risk |
risk factor |
Estrogen resistance syndrome, Estrogen resistance syndrome |
| RS1562789302 |
SAMD9L
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-pancytopenia syndrome, Spinocerebellar ataxia 49 |
| RS1562795586 |
SAMD9L
|
Health Risk |
Likely pathogenic |
— |
| RS1562800908 |
RMND1
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined oxidative phosphorylation defect type 11, Abnormality of the nervous system |
| RS1562805960 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS1562806242 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS1562806273 |
SGCE
|
Health Risk |
Pathogenic |
— |
| RS1562811414 |
SGCE
|
Health Risk |
Pathogenic/Likely pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS1562811734 |
SLC25A13
|
Health Risk |
Likely pathogenic |
Citrullinemia, type II |
| RS1562811980 |
SGCE
|
Health Risk |
Pathogenic |
— |
| RS1562812136 |
SGCE
|
Health Risk |
Pathogenic |
— |
| RS1562812370 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS1562817048 |
ASNS
|
Health Risk |
Pathogenic |
Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome, Congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome |
| RS1562817224 |
SLC26A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Deafness, Hearing loss |
| RS1562817529 |
SLC26A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Deafness, Hearing loss |
| RS1562818383 |
PUS7
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with abnormal behavior, microcephaly |
| RS1562818685 |
SLC26A4
|
Health Risk |
Pathogenic |
— |
| RS1562822565 |
SLC26A4
|
Health Risk |
Pathogenic |
Deafness, Hearing loss |
| RS1562822698 |
SLC26A4
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 4, Pendred syndrome |
| RS1562823061 |
SLC25A13
|
Health Risk |
Conflicting classifications of pathogenicity |
Citrullinemia, type II |
| RS1562823624 |
ASNS
|
Health Risk |
Pathogenic |
— |
| RS1562831563 |
SLC25A13
|
Health Risk |
Pathogenic/Likely pathogenic |
Citrullinemia, type II |
| RS1562831765 |
SLC25A13
|
Health Risk |
Pathogenic |
Neonatal intrahepatic cholestasis due to citrin deficiency, Citrin deficiency |
| RS1562831788 |
SLC25A13
|
Health Risk |
Conflicting classifications of pathogenicity |
Citrin deficiency, Citrin deficiency |
| RS1562835391 |
SLC26A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Deafness, Hearing loss |
| RS1562835480 |
SLC26A4
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 4, Autosomal recessive nonsyndromic hearing loss 4 |
| RS1562835515 |
SLC26A4
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 4, Pendred syndrome |
| RS1562837305 |
SLC26A4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1562837561 |
TFR2
|
Health Risk |
Pathogenic |
Hereditary hemochromatosis, Hemochromatosis type 3 |
| RS1562837669 |
TFR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary hemochromatosis, Hemochromatosis type 3 |
| RS1562838535 |
TFR2
|
Health Risk |
Pathogenic |
Hereditary hemochromatosis, Hereditary hemochromatosis |
| RS1562839439 |
SLC26A4
|
Health Risk |
Pathogenic |
Pendred syndrome, Pendred syndrome |
| RS1562840744 |
FKBP14
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type |
| RS1562842409 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS1562842708 |
PEX1
|
Health Risk |
Likely pathogenic |
Heimler syndrome 1, Peroxisome biogenesis disorder 1B |
| RS1562844289 |
SLC25A13
|
Health Risk |
Pathogenic |
Citrin deficiency, Citrin deficiency |